Skip to main content

Table 1 Country-specific profiles of the 72 GAVI-eligible countries

From: Health and economic impact of rotavirus vaccination in GAVI-eligible countries

Countrya GNI per capita (2008 US$) GAVI grouping for co-financingb DTP3 coverage (2008) Under 5 child mortality (per 1,000 live births) (2006) Under 5 rotavirus mortality (per 100000 children <5) (2004) Percentage of death due to diarrhea among children under 5 (2000)
AFR D       
   Angola 3,450 4 81% 260 389 19.1
   Benin 690 1 93% 148 182 17.1
   Burkina Faso 480 1 99% 204 256 18.8
   Cameroon 1,150 3 84% 149 179 17.3
   Chad 530 1 43% 209 266 18.1
   Comoros 750 1 81% 68 64 13.6
   Ghana 670 2 87% 120 92 12.2
   Guinea 390 1 70% 161 188 16.5
   Guinea-Bissau 250 1 79% 200 283 18.6
   Liberia 170 4 92% 235 331 17.3
   Madagascar 410 1 88% 115 141 16.9
   Mali 580 1 99% 217 307 18.3
   Mauritania 840 1 74% 125 153 16.2
   Niger 330 1 89% 253 392 19.8
   Nigeria 1,160 2 57% 191 228 15.7
   Sao Thome 1,020 1 99% 96 129 16.0
   Senegal 970 1 88% 116 158 17.1
   Sierra Leone 320 4 87% 269 439 19.7
   The Gambia 390 1 96% 114 107 12.2
   Togo 400 1 89% 107 134 13.8
AFR E       
   Burundi 140 4 92% 181 255 18.2
   Central African Republic 410 4 51% 174 210 14.7
   Congo 1,970 4 89% 126 86 11.2
   Cote d'Ivoire 980 4 74% 127 223 14.8
   Democratic Republic of the Congo 150 4 83% 205 281 18.1
   Eritrea 300 4 85% 74 84 15.6
   Ethiopia 280 1 81% 123 213 17.3
   Kenya 770 2 85% 121 135 16.5
   Lesotho 1,080 1 91% 132 25 3.9
   Malawi 290 1 91% 120 225 18.1
   Mozambique 370 1 80% 138 183 16.5
   Rwanda 410 1 97% 160 272 18.5
   Tanzania 430 1 84% 118 147 16.8
   Uganda 420 1 79% 134 165 17.2
   Zambia 950 1 95% 182 227 17.5
   Zimbabwe c 2 75% 85 106 12.1
AMR A, B & D       
   Cuba c 2 99% 7 1 1.3
   Guyana 1,420 3 93% 62 119 21.4
   Honduras 1,800 3 93% 27 43 12.2
   Bolivia 1,460 3 83% 61 66 14.3
   Haiti 660 4 53% 80 133 16.5
   Nicaragua 1,080 2 96% 26 30 12.2
EMR D       
   Afghanistan c 4 85% 257 338 18.9
   Djibouti 1,130 3 89% 130 145 16.6
   Pakistan 980 2 73% 97 95 14.0
   Somalia c 4 31% 145 315 18.7
   Sudan 1,130 4 93% 89 79 12.9
   Yemen 950 1 87% 100 108 16.1
EUR B & C       
   Armenia 3,350 3 89% 24 29 10.5
   Azerbaijan 3,830 3 95% 89 125 15.3
   Georgia 2,470 3 92% 32 42 11.5
   Kyrgyzstan 740 2 95% 41 86 14.1
   Tajikistan 600 2 86% 68 177 16.4
   Uzbekistan 910 2 98% 44 88 14.8
   Moldova 1,470 2 95% 19 5 2.0
   Ukraine 3,210 3 90% 24 2 1.2
SEAR B & D       
   Indonesia 2,010 3 77% 34 60 18.3
   Korea, Democratic Republic c 2 92% 55 56 18.9
   Sri Lanka 1,790 3 98% 13 16 13.5
   Timor Leste 2,460 4 79% 55 115 21.9
   Bangladesh 520 1 87% 69 89 20.0
   Bhutan 1,900 1 96% 70 98 20.9
   India 1,070 2 84% 76 102 20.3
   Myanmar c 1 85% 104 128 21.1
   Nepal 400 1 82% 59 91 20.5
WPR B       
   Cambodia 600 1 91% 82 226 16.6
   Kiribati 2,000 3 82% 64 127 21.9
   Lao People Democratic Republic 750 1 61% 75 122 15.6
   Mongolia 1,680 2 96% 42 67 14.5
   Papua New Guinea 1,010 2 52% 73 128 15.3
   Solomon Islands 1,180 1 78% 72 45 8.8
   Viet Nam 890 2 93% 17 21 10.4
  1. a The six WHO geographical regions are the African Region (AFR), Eastern Mediterranean Region (EMR), Region of the Americas (AMR), European Region (EUR), South-East Asian Region (SEAR), and Western Pacific Region (WPR). Categories for mortality rates include very low child, very low adult mortality (A), low child, low adult mortality (B), low child, high adult mortality (C), high child, high adult mortality (D), and high child and very high adult mortality (E). Combining the two dimensions, we modeled 36 countries from AFR (with 20 in AFR D and 16 in AFR E); 6 countries from EMR D; 6 countries from AMR A, B & D; 8 countries from EUR B & C; 9 countries from SEAR B & D; and 7 countries from WPR B.
  2. b The GAVI Alliance new vaccine co-financing policy (which came into effect in 2008) requires GAVI-eligible countries to share new vaccine costs at one of four levels depending on the country's ability to pay: (1) Poorest group countries will pay $0.20/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines; (2) Intermediate group countries will pay $0.30/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines; (3) Least Poor group countries will pay $0.20/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines for the first year, but will increase their copayment by 15% annually; and (4) Fragile group countries will pay $0.10/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines.
  3. c Data are not available.